Background Corticotropin-releasing factor (CRF) peptides exert profound effects on the secretomotor function of the gastrointestinal tract. Nevertheless, despite the presence of CRF peptides and receptors in colonic tissue, their influence on colonic blood flow (CBF) is unknown. Aim To determine the effect and mechanism of members of the CRF peptide family on CBF in isoflurane-anesthetized rats. Methods Proximal CBF was measured with laser-Doppler flowmetry simultaneously with mean arterial blood pressure (MABP) measurement. Rats were injected with intravenous human/rat CRF (CRF 1 [ CRF 2 affinity), mouse urocortin 2 (mUcn2, selective CRF 2 agonist), or sauvagine (SVG, CRF 2 [ CRF 1 affinity) at 1-30 lg/kg. The nitric oxide (NO) synthase inhibitor, L-NAME (3 mg/ kg, iv), the cyclooxygenase inhibitor, indomethacin (Indo, 5 mg/kg, ip), or selective CRF 2 antagonist, astressin 2 -B (Ast 2 B, 50 lg/kg, iv) was given before SVG injection (10 lg/kg, iv). Results SVG and mUcn2 dose-dependently increased CBF while decreasing MABP and colonic vascular resistance (CVR). CRF had no effect on CBF, but increased CVR. The hyperemic effect of SVG was inhibited by L-NAME but not by Indo, whereas hypotension was partially reduced by L-NAME. Sensory denervation had no effect on SVG-induced changes. Ast 2 B inhibited SVGinduced hyperemia and decreased CVR, and partially reduced the hypotension. Conclusions Peripheral CRF 2 activation induces colonic hyperemia through NO synthesis, without involving prostaglandin synthesis or sensory nerve activation, suggesting a direct action on the endothelium and myenteric neurons. Members of the CRF peptide family may protect the colonic mucosa via the activation of the CRF 2 receptor.
Introduction
The gastrointestinal tract receives up to 25 % of the total cardiac output of which nearly 80 % flows through the mucosal and submucosal layers [1] , implying that the high metabolic need of mucosal cells combined with the constant exposure to luminal noxious agents emphasizes the importance of the regulation of the enteric microcirculation to physiology. The mucosal microcirculatory defense concept is well established in the upper gastrointestinal tract, where the mucosa is regularly exposed to luminal acid [2] [3] [4] . Similarly, in the lower intestine, blood flow helps prevent mucosal oxidative stress, increased mucosal permeability, and bacterial translocation [5] .
Gastrointestinal blood flow is regulated by sensory afferent nerve-mediated reflexes [6] in series or in parallel with other mediators including nitric oxide (NO), calcitonin gene-related peptide (CGRP), and prostaglandins (PGs) [2, [7] [8] [9] ]. An emerging signaling pathway implicated in the gut response to noxious stimuli includes the action of corticotropin-releasing factor (CRF)-related peptides, which mediate and modify stress-induced endocrine, behavioral, autonomic, and immune responses [10] . The mammalian CRF peptide family consists of 4 distinct paralogs, including CRF and urocortins (Ucn 1, 2, and 3) [10] [11] [12] . In non-mammalian vertebrates, CRF peptide orthologs include frog sauvagine [13] and fish urotensin-I [14] . These peptides exert their effects by activating two class B1 G-protein-coupled receptors, the CRF receptor 1 (CRF 1 ) [15] , or CRF 2 [16] [17] [18] [19] . CRF is a nonselective peptide with affinity CRF 1 [ CRF 2 , whereas urocortin (Ucn1), also nonselective peptide, has equivalent and high affinity to CRF 1 and CRF 2 receptors. Urocortin 2 (Ucn 2) and 3 (Ucn 3) in contrast are selective agonists to CRF 2 receptors [20] . Amphibian sauvagine is a nonselective CRF peptide with higher affinity to CRF 2 than CRF 1 [21] .
CRF signaling, in addition to its involvement in stressrelated gastrointestinal secretomotor and pain responses [22] [23] [24] , also affects hemodynamics when injected centrally or peripherally. In sheep with experimental heart failure, intravenous (iv) Ucn 1 improves hemodynamics by increasing cardiac output and decreasing vascular resistance [25] . Intracisternal CRF affects hepatic microcirculation via CRF 2 receptor activation in rats [26] . Topical Ucn2 increases coronary blood flow via CRF 2 receptor activation [27] . Ucn2 injected iv to healthy humans increases cardiac output, heart rate, and left ventricular ejection while decreasing systemic vascular resistance [28] . CRF, sauvagine, and urotensin increase mesenteric blood flow when injected centrally [29] . The presence of CRF receptors in colonic tissue both in humans [30, 31] and in rodents [22, 32, 33] predicts their possible role in the modulation of colonic mucosal blood flow, an enteric defense factor. Yet, the effect of peripheral CRF signaling on colonic mucosal blood flow is thus far unknown.
Here, we investigated the effects of iv injections of members of the CRF peptide family: CRF (CRF 1 [ CRF 2 affinity), mouse urocortin 2 (mUcn2, selective CRF 2 agonist), and sauvagine (SVG, CRF 2 [ CRF 1 affinity) on colonic blood flow, mean arterial pressure and vascular resistance in the anesthetized rat. Colonic CRF 2 activation increased colonic blood flow primarily through local NO pathway without involving PGs or extrinsic afferent neurons.
Methods

Animals
Male Sprague-Dawley rats weighing 200-250 g (Harlan, San Diego, CA) were used. All studies were performed with approval of the Veterans Affairs Greater Los Angeles Healthcare System Institutional Animal Care and Use Committee (VA IACUC). Chemicals CRF, mUcn2, SVG, and astressin 2 -B (Ast 2 B) were synthesized [34] and provided by Dr. Rivier (Salk Institute, Peptide Laboratories). N G -nitro-L-arginine methyl ester (L-NAME), indomethacin (Indo), capsaicin, HEPES, and other chemicals were obtained from Sigma Chemical (St. Louis, MO). Krebs solution contained (in mM) 136 NaCl, 2.6 KCl, 1.8 CaCl 2 , and 10 HEPES at pH 7.4. Each solution was prewarmed to 37°C using a water bath, with temperature maintained during the experiment with a heating pad. For stock solutions, capsaicin was dissolved in 10 % TweenÓ-80, 10 % ethanol, and 80 % saline, and the solvent was used as a vehicle. For iv injection, agonists or antagonists were freshly dissolved in saline containing 0.1 % bovine serum albumin (BSA). Saline containing BSA was used as a vehicle control.
Measurement of Colonic Blood Flow
Under isoflurane anesthesia (1.5-2.0 %) using a rodent anesthesia inhalation system (Summit Medical Systems, Bend, OR), rats were placed supine on a heating block system with warmed recirculating water (Summit Medical) to maintain body temperature at 36-37°C, as monitored by a rectal thermistor. Prewarmed saline was infused via the right femoral vein at 1.08 ml/h using a Harvard infusion pump (Harvard Apparatus, Holliston MA); blood pressure was monitored via a catheter placed in the left femoral artery using a pressure transducer (Kent Scientific, Torrington, CT). Colonic blood flow was measured with laserDoppler flowmetry by modified method as previously described [3] .
The cecum and proximal colon were exposed via a midline incision. The cecum and mid-colon, 3-cm caudal from the cecum, were loosely ligated with nylon suture, and the proximal colon segment was filled with 1 ml saline prewarmed at 37°C. A *2-cm incision was made in the anterior wall of the segment using a thermal cautery (Geiger Medical Technologies, Inc., Monarch Beach, CA) to expose the colonic mucosa. Luminal contents and feces were gently removed, followed by rinsing the lumen with warmed saline. A concave stainless steel disk (16-mm diameter and 1-2 mm deep) with a 3-mm central aperture was fixed watertight on the mucosal surface with a silicone plastic adherent (Silly Putty, Binney & Smith, Easton, PA). The serosal surface of the colon was supported with a laserDoppler flow probe (described below). A thin plastic cover slip was fixed to the disk with the silicone adherent to permit closed superfusion with solutions at a rate of 0.25 ml/min by means of a Harvard infusion pump.
For the measurement of colonic blood flow, a right-angle probe (R-type, Transonic, Ithaca, NY) was surrounded with a silicone plastic adherent and attached on the colonic serosa just below the chambered mucosa. Blood flow was measured as the voltage output of the laser-Doppler instrument (model BLF21, Transonic) and was expressed relative to the stable level (the basal level) *60 min after the superfusion started. Blood flow and blood pressure were continuously recorded with a strip chart recorder.
Animals had free access to water and food before the experiments, since our preliminary studies showed that, regardless of the surgical stress, colonic blood flow was unstable over time and the effects of CRF peptides on blood flow were irreproducible following an overnight fast, presumably due to excessive stress.
Experimental Protocol
Blood flow was stabilized during a continuous perfusion of pH 7.4 Krebs buffer, after which the time was set as t = 0 min. Because of the laparotomy and surgical stress, the stabilization of colonic blood flow usually took [1 h. The colonic mucosa was continuously superfused at 0.25 ml/min with pH 7.4 Krebs buffer throughout the experiments as in our previous duodenal superfusion [35, 36] . Colonic blood flow (CBF) and mean arterial blood pressure (MABP) were simultaneously measured every 5 min and expressed as % basal and mmHg, respectively. Colonic vascular resistance (CVR) was calculated as an equation, CVR (% basal) = MABP (% basal at t = 0)/CBF (% basal) 9 100 as in a previous study [37] .
To examine the dose-dependent effect of the CRF peptide family on the proximal colonic blood flow, after 10-min baseline measurement (t = 0-10 min), 1-30 lg/kg of CRF, mUcn2, or SVG in 0.1 ml BSA-saline solution was iv injected every 10 min followed by gentle flushing iv line with 0.1 ml BSA-saline.
To investigate the involvement of NO or PGs in the effects of SVG, the animals were given the NO synthase (NOS) inhibitor L-NAME (3 mg/kg, iv at t = 10 min) or pretreated, 1 h before the experiments, with indomethacin [Indo (5 mg/kg, ip)] an inhibitor of cyclooxygenase and production of PGs that are known to affect intestinal blood flow [2, [7] [8] [9] , followed by SVG (10 lg/kg) iv injection at t = 20 min. Some animals were pretreated with the high dose of capsaicin (Cap-t, 125 mg/kg, sc) or vehicle (veh-t) in order to denervate sensory nerves 10-14 days prior to the experiments as previously described [3] .
To confirm the receptor specificity of SVG, a selective CRF 2 receptor antagonist Ast 2 B (50 lg/kg, iv) [34] was injected 10 min before SVG injection. The doses of CRF ligands and Ast 2 B were adopted from our prior studies [38, 39] . SVG was used in these studies as a pharmacological tool based on its higher potency, than Ucn2, in inducing CRF 2 -mediated vagal efferent activity [40] and in attenuating visceral pain responses in rats (unpublished data).
Statistics
All data from six rats in each group are expressed as mean ± SEM. Comparisons between groups were made by one-way ANOVA followed by Fischer's least significant difference test. P values of 0.05 were taken as significant.
Results
Dose-Dependent Effect of CRF Peptides on CBF, MABP and CVR CBF and MABP were stable during perfusion with pH 7.4 Krebs solution in control group for *1 h (Fig. 1a-c) . CRF iv injection somewhat decreased CBF with stable MABP, significantly increasing CVR at the 3 and 10 lg/kg doses. In contrast, mUcn2 or SVG dose-dependently increased CBF (Fig. 1a) with a decrease in MABP (Fig. 1b) , decreasing CVR (Fig. 1c) . The effects of SVG on MABP and CVR were more potent than those of mUcn2 at 3 and 10 lg/kg (p \ 0.05). Figure 1d , e depicts dose-response curve of the peak response in CBF and CVR to CRF peptides. The maximum response to mUcn2 and SVG was achieved at the 10 lg/kg dose.
Effects of L-NAME and Indo on SVG-Induced Colonic Hyperemia
Based on the dose-dependent effect and potency on CBF as above, we chose SVG iv injection at the 10 lg/kg dose for the following experiments to examine the mechanism involved in the blood flow response in rat colon. SVG iv injection (10 lg/kg) increased CBF (Fig. 2a) with a decrease in MABP (Fig. 2b) , markedly decreasing CVR (Fig. 2c) . L-NAME iv injection (3 mg/kg) rapidly increased MABP with no effect on CBF (t = 10-20 min). L-NAME pretreatment abolished SVG-induced hyperemia and reduced SVG-induced hypotension, preventing the SVG-induced CVR decrease. Alternatively, SVG injection after L-NAME treatment decreased CBF and reversed L-NAME-induced hypertension to hypotension. In contrast, Indo pretreatment (5 mg/kg, ip) had no effect on SVG-induced hypotension, but partially enhanced hyperemia, resulting in more decrease in CVR.
Capsaicin-Sensitive Afferent Nerves in SVG-Induced Hyperemia
In vehicle-treated rats, SVG (10 lg/kg, iv) increased CBF (Fig. 3a) accompanied by hypotension (Fig. 3b ) and decreased CVR (Fig. 3c) . Capsaicin pretreatment (Cap-t, 125 mg/kg, sc) had no effect on CBF, MABP, or CVR during the basal period (t = 0-10 min). Cap-t had no effect on SVG-induced changes in CBF (Fig. 3a) , MABP (Fig. 3b) , or CVR (Fig. 3c) . This result suggests that the activation of sensory nerves is not involved in SVGinduced colonic vasodilation. Since SVG is a preferable CRF 2 receptor agonist, we confirmed whether SVG-induced changes were mediated via CRF 2 receptor activation. The selective CRF 2 receptor antagonist Ast 2 B (50 lg/kg, iv) was injected prior to SVG injection. Ast 2 B injection had no effect on CBF, MABP, or CVR (t = 10-20 min). Ast 2 B injection abolished SVG-induced hyperemia ( Fig. 4a ) and inhibited the associated hypotension (Fig. 4b) , strongly inhibiting the CVR decrease (Fig. 4c) . This result suggests that SVG-induced colonic hyperemia is selectively mediated via CRF 2 receptor activation.
Discussion
We demonstrate that, in isoflurane-anesthetized rats, peripheral CRF 2 receptor activation increases colonic blood Fig. 2 Effects of L-NAME and indomethacin (Indo) pretreatment on sauvagine (SVG)-induced hyperemia in rat proximal colon. SVG (10 lg/kg, iv) increased colonic blood flow (a) accompanied by a decrease in MABP (b), decreasing vascular resistance (c). L-NAME (3 mg/kg, iv) increased vascular resistance and inhibited SVG-induced hyperemia and vascular dilatation. Indo pretreatment (5 mg/kg, sc) sustained SVGinduced hyperemia and enhanced vascular resistance decrease. Each datum is expressed as mean ± SEM (n = 6). *p \ 0.05 versus control, p \ 0.05 versus SVG iv alone flow through a NO-dependent mechanism but not involving PG synthesis or sensory nerve activation. Similarly, iv injection of CRF 2 agonists potently induced hypotension in part through NO. L-NAME abolished the iv SVG-induced decrease in CVR while only modestly reducing SVGinduced hypotension. The data suggest that the CRF 2 -mediated hypotension is in part due to the peripheral vasodilatation via NO, but may also involve cardiac effects on the systemic hemodynamics as previously reported [27] . The regulation of intestinal blood flow involves capsaicin-sensitive afferent C-fiber-mediated reflex and several locally produced enteric neuromodulators and transmitters including PGs, CGRP, and NO [2, [6] [7] [8] [9] . The present study provides the first evidence that CRF peptides induce colonic hyperemia in anesthetized rats through CRF 2 receptor activation, demonstrated by the robust blood flow response following iv administration of the selective CRF 2 agonist mUcn2 [20] and SVG, a peptide with affinity CRF 2 [ CRF 1 [21] in contrast to the effect of native CRF with higher affinity to CRF 1 [21] , which exerted little to no effect. This is further confirmed by the blockade of the effects of SVG by the selective CRF 2 receptor antagonist, Fig. 3 Effect of afferent denervation on sauvagine (SVG)-induced hyperemia in rat proximal colon. Capsaicin treatment (125 mg/kg, sc; Capt) had no effect on SVG-induced hyperemia (a), hypotension (b), or vascular dilatation (c). Each datum is expressed as mean ± SEM (n = 6). *p \ 0.05 versus control Dig Dis Sci (2015) 60:858-867 863
Ast 2 B. Given that the peripherally administered CRF peptides do not cross the blood brain barrier [29, 41, 42] , the likely site of action of the observed colonic blood flow is decidedly peripheral. The effect of mUcn2 and SVG was dose-dependent up to the 10 lg/kg dose, but became less robust at 30 lg/kg, possibly due to action on CRF 1 or due to a CRF 2 -CRF 1 receptor cross talk where lower doses of centrally injected mUcn2 showed no effect on colonic motor response but when given at a fivefold higher doses than CRF, it stimulated colonic motor response through a CRF 1 activation [38, 43] .
Interestingly, the effect of SVG was similar to those of mUcn2, with regard to blood flow, although SVG more strongly reduced MABP. Although SVG binds to CRF 1 , albeit at a lesser affinity than to CRF 2 , its more pronounced hypotensive effect cannot be due to its potential effect on CRF 1 , because CRF, with its higher affinity to CRF 1 , does not affect any of the hemodynamic endpoints measured. In dogs injected intracerebroventricularly (icv) with either SVG or CRF, only SVG increased mesenteric blood flow [29] . SVG injected subcutaneously (sc) is also more potent than CRF (sc) in inhibiting food intake in rats [44] . Nonetheless, the maximal effects of SVG (10 lg/kg) on colonic blood flow, systemic blood pressure, and vascular resistance were all prevented by pretreatment with the selective CRF 2 antagonist Ast 2 B suggesting that the effects of mUcn2 or SVG on colonic blood flow and vascular resistance are mediated through CRF 2 .
Our data further show that CRF 2 -mediated colonic hyperemia involves NO but not PG or afferent nerve fibers as shown by the blockade of the response by pretreatment with L-NAME but not by Indo or capsaicin. Although NO and PG affect acid-induced gastric mucosal hyperemia [45, 46] and the gastric microcirculation [47] , PG has no effect on the CRF 2 -mediated colonic hyperemia. Similarly, CRF 2 -mediated colonic hyperemia does not involve capsaicin-sensitive afferent fibers. Taken together, these data suggest that CRF 2 receptor ligands induce colonic hyperemia most likely through a direct release of NO, similar to our prior report that CRF 2 receptors are present in the colonic vascular endothelium [33] and co-localize with neuronal NOS in enteric neurons [22] . Endothelial and neuronal NO induces capsaicin-induced gastric mucosal hyperemia [48, 49] , reinforcing the notion that CRF 2 -mediated endothelial and neuronal NO release in the colon be directly vasodilatory.
An intriguing finding in the present study is the anomalous increase in CRF 2 -mediated colonic mucosal blood flow and the decrease in MABP and vascular resistance following pretreatment with Indo, which cannot be explained from the data we present in this study, but may be inferred from the variable vascular responses reported to EP receptor activation. For instance, in mouse kidney, low-dose PGE 2 vasoconstricts through EP1 and EP3 receptors but at a higher dose vasodilates through activation of EP2 and EP4 [50] . Similarly, PGs administered centrally and systemically exert differing effects dependent on the receptor types involved [51] . Alternatively, Indo may exert differential effects depending on the physiological state of the tissue. For instance, in hypertensive but not in normotensive dogs, Indo increases renal blood flow [52] . Whether the presence of CRF 2 activation in rats constitutes a different state in which Indo enhances the CRF 2 -mediated blood flow response needs further studies. Taken together, it is likely that Indo, by preventing or reducing PG synthesis, reduces EP1-or EP3-mediated vasoconstriction, thereby enhancing the CRF 2 -mediated NO-dependent vasodilatation.
In conclusion, peripheral CRF 2 receptor activation induces colonic hyperemia through NO but not through the PG pathway or through capsaicin-sensitive afferent fibers. The data suggest that members of the CRF peptide family may protect the mucosa via the activation of the CRF 2 receptors in the rat lower intestine. Overall, the protective effects of CRF 2 against ischemia-/reperfusion-induced cardiac myocyte injury (see [53] ), its anti-angiogenic effect in the inflamed colon [54] , and our finding of colonic mucosal hyperemia strongly suggest that peripheral CRF 2 signaling is a key component of the hemodynamic regulatory system in normal and in disease states. Of note is that the effect of CRF peptides on mesenteric blood flow could be different in awake versus anesthetized state, as intestinal motility per-se can influence blood flow [55] . However, in awake rats, CRF 2 activation by Ucn2 in awake rodents does not have effect on the basal colonic transit. Thus, the increased mucosal blood flow due to Ucn2 or SVG is unlikely to be due to increased intestinal motility. As such, while the anesthetized rat model is a limitation in the current study and extrapolation to awake-state mucosal blood flow needs caution, the model has the advantage to study the direct effect of CRF peptides on mucosal blood flow without the confounding factor of the awake-state intestinal motility.
